MedPath

Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID

Recruiting
Conditions
Arterial Stiffness
Quality of Life
Persistent COVID-19
Lifestyles
Registration Number
NCT05819840
Lead Sponsor
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Brief Summary

The ICOPER study aims to analyze the structure, vascular function, vascular aging and determining factors in 300 adults diagnosed with Persistent Covid in the field of Primary Health Care.

Detailed Description

Objective: To analyze the structure, the vascular function, the vascular aging and the determining factors in adults with a diagnosis of Persistent Covid and the differences by gender.

Design: Cross-sectional descriptive observational study. Setting: The study will be carried out at the Salamanca Primary Care Research Unit (APISAL). Study Subjects: The study includes the basis of the Persistent Covid Monographic consultation in the Internal Medicine Service of the University Hospital of Salamanca and the subjects with the diagnosis of Persistent Covid in the MEDORA Primary Care clinical history. Thus, 300 subjects have been obtained who are diagnosed with Persistent Covid, who meet the diagnostic criteria established by the Spanish Society of General and Family Physicians and sign the informed consent.

Measurements: The variables reflected in the Integrated Assistance process for the Care of People Affected by SARS CoV-2 of the Junta de Castilla y León will be collected, to evaluate the functional status of the patient and persistent symptoms, their impact on activities of daily life and quality of life of patients with Persistent Covid and the perception of their health. Lifestyles (diet, physical activity, tobacco and alcohol), psychological factors and cognitive impairment will be collected using validated questionnaires, and physical activity will be objectively measured with a 7-day pedometer. Vascular structure and function will be analyzed by measuring the thickness of the carotid intima media (Sonosite Micromax); pulse wave analysis and carotid-femoral pulse wave velocity (VOPcf) (Sphygmocor System). Cardio Ankle Vascular Index (CAVI), ankle-brachial pulse wave velocity (VOPbt) and ankle-brachial index (Vasera VS-2000®). Vascular aging will be calculated using the 10 and 90 percentiles of the VOPcf and the VOPbt. Demographic, analytical variables and to assess retinal, cardiac, renal, cerebral vascular lesion and cardiovascular risk will be collected.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • History of probable or confirmed SARS-CoV-2 infection, usually 3 months after onset, with symptoms that last at least 2 months and cannot be explained by an alternative diagnosis.
  • Common symptoms should include fatigue, shortness of breath, and cognitive dysfunction, and an impact on daily functioning.
Exclusion Criteria
  • Subjects in a terminal situation.
  • Inability to travel to health centers.
  • Presenting a history of cardiovascular disease (ischemic heart disease or cerebrovascular disease).
  • Glomerular filtration rate of less than 30%.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pulse Wave Velocity1 year

Measurement by SphygmoCor System (meters/seg)

Secondary Outcome Measures
NameTimeMethod
Drinking habits1 year

Measurement by a frequency alcohol questionnaire (units/day)

Psychological factors1 year

Goldberg Anxiety and Depression Scale

Cognitive evaluation1 year

Measurement by Montreal Cognitive Assessment (MOCA) (points). Range: 0-30 points. A score of 26 points or above is considered normal.

Eating habits1 year

Mediterranean Diet Adherence PREDIMED Questionnaire

Carotid intima-media thickness (IMT)1 year

Measurement by Sonosite Micromax Ultrasound (mm)

Cardio Ankle Vascular Index (CAVI)1 year

Measurement by Vasera device 2000 (not units)

Physical Activity1 year

World Questionnaire on Physical Activity (GPAQ)

Smoking1 year

Measurement by a questionnaire of four questions adapted from the WHO MONICA study

Trial Locations

Locations (1)

Primary Care Research Unit of Salamanca (APISAL)

🇪🇸

Salamanca, Spain

Primary Care Research Unit of Salamanca (APISAL)
🇪🇸Salamanca, Spain
Olaya Tamayo Morales
Contact
923177831
olayatm@usal.es

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.